Does RUXOLITINIB Cause Therapy interrupted? 165 Reports in FDA Database

Q: Does RUXOLITINIB cause Therapy interrupted?

165 reports of Therapy interrupted have been filed with the FDA for RUXOLITINIB, representing 0.2% of all RUXOLITINIB adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Therapy interrupted have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.

165

Reports of Therapy interrupted with RUXOLITINIB

0.2%

of all RUXOLITINIB reports

Deaths

Hospitalizations

How Dangerous Is Therapy interrupted From RUXOLITINIB?

Of the 165 reports, 25 (15.2%) required hospitalization, and 1 (0.6%) were considered life-threatening.

Is Therapy interrupted Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 165 reports have been filed with the FAERS database.

What Other Side Effects Does RUXOLITINIB Cause?

Off label use (12,492) Death (6,561) Fatigue (5,663) Anaemia (3,593) Haemoglobin decreased (3,297) Platelet count decreased (3,028) Diarrhoea (2,531) Asthenia (2,529) Dizziness (2,398) Pneumonia (2,343)

What Other Drugs Cause Therapy interrupted?

ADALIMUMAB (5,755) ETANERCEPT (3,397) RELUGOLIX (3,251) CERTOLIZUMAB PEGOL (3,209) LENALIDOMIDE (2,724) UPADACITINIB (1,741) ABATACEPT (1,726) CLOZAPINE (1,722) AMIKACIN (1,283) TOFACITINIB (1,182)

Which RUXOLITINIB Alternatives Have Lower Therapy interrupted Risk?

RUXOLITINIB vs SABRIL RUXOLITINIB vs SACCHAROMYCES CEREVISIAE RUXOLITINIB vs SACITUZUMAB GOVITECAN RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY RUXOLITINIB vs SACROSIDASE

RUXOLITINIB Full Profile All Therapy interrupted Reports All Drugs Causing Therapy interrupted RUXOLITINIB Demographics